MapLight Therapeutics, Inc. (MPLT) stock
MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.65+0.08 (+1.22%)
Close on Nov 18, 2026Market cap $308.41MP/E –Yield –
MapLight Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MapLight Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$174.67M. For fiscal 2025 it was -$138.14M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$138.14M | – |
| FY2024 | Dec 31, 2024 | -$78.82M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$44.87M | – |
| Q1 FY2026 | Mar 31, 2026 | -$51.18M | – |
| Q4 FY2025 | Dec 31, 2025 | -$46.83M | – |
| Q3 FY2025 | Sep 30, 2025 | -$31.79M | – |
| Q2 FY2025 | Jun 30, 2025 | -$33.97M | – |
| Q1 FY2025 | Mar 31, 2025 | -$25.55M | – |
| Q4 FY2024 | Dec 31, 2024 | -$21.49M | – |
See a number that looks wrong?